Archives

NICE has launched a new online tool for healthcare professionals, which brings together all connected NICE guidance on a topic in a user-friendly electronic flowchart. Previously, there has been [...]

This guidance is concerned with the identification and management of common mental health disorders such as depression, generalised anxiety disorder, panic disorder, obsessive-compulsive [...]

People with schizophrenia have an increased risk of cardiovascular mortality. Some atypical antipsychotics, in particular clozapine, olanzapine and quetiapine, have adverse metabolic effects such [...]

Pharmacovigilance is the process involving detection, assessment, understanding and prevention of adverse effects of medication. The MHRA have produced an online learning module on this topic for [...]

The Royal College of Psychiatrists (RCPsych) have reviewed existing standards and regulations and recommend a checklist of 10 minimum standards for assessing mental health wards. One of these [...]

There is a national shortage of trifluoperazine tablets and there will be serious supply problems for several months. Trifluoperazine liquid may be available, but alternative medication may have [...]

The Welsh Medicines Partnership has produced a comprehensive and well-referenced educational pack (72 pages) on prescribing anxiolytics and hypnotics in primary and secondary care. It explains [...]